Literature DB >> 18573589

Survival rate and factors associated with 1-month survival of witnessed out-of-hospital cardiac arrest of cardiac origin with ventricular fibrillation and pulseless ventricular tachycardia: the Utstein Osaka project.

Tatsuya Nishiuchi1, Yasuaki Hayashino, Shunichi Fukuhara, Taku Iwami, Yasuyuki Hayashi, Atsushi Hiraide, Hisashi Ikeuchi, Hidekazu Yukioka, Tetsuya Matsuoka.   

Abstract

OBJECTIVE: We reassessed 1-month survival of patients with witnessed out-of-hospital cardiac arrest (OHCA) of cardiac origin with ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT) in Osaka, Japan, and identified factors associated with 1-month survival using updated data from 1998 to 2004 collected based on the Utstein Style.
METHODS: Using the Utstein Osaka Project database, we analyzed 1028 cases which met the following criteria: (1) patient age 18 years or older; (2) presumed cardiac origin based on the definition of the Utstein Style; (3) witnessed by citizens; (4) VF or pulseless VT at the time of arrival of the ambulance. The main outcome measure was survival at 1 month after collapse. Variables to develop a predictive model for 1-month survival were selected by stepwise logistic regression.
RESULTS: Survival at 1 month was 19.6%. Factors retained in the final logistic regression were age, sex, type of witness, and time interval from (a) ambulance call receipt to cardiopulmonary resuscitation (CPR) by the ambulance crew; (b) ambulance call to defibrillation; (c) CPR by the ambulance crew to hospital arrival. Area under the receiver-operating characteristic curve for the model developed with the six variables was 0.738 and Hosmer-Lemshow goodness-of-fit p-value was 0.94.
CONCLUSION: We successfully developed a model to estimate the probability of 1-month survival using variables easy to collect in the early phase of resuscitation, and this model would help physicians and family members predict the likelihood of 1-month survival of OHCA patients on admission.

Entities:  

Mesh:

Year:  2008        PMID: 18573589     DOI: 10.1016/j.resuscitation.2008.04.001

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  5 in total

1.  Bystander-initiated CPR in an Asian metropolitan: does the socioeconomic status matter?

Authors:  Wen-Chu Chiang; Patrick Chow-In Ko; Anna Marie Chang; Wei-Ting Chen; Sot Shih-Hung Liu; Yu-Sheng Huang; Shey-Ying Chen; Chien-Hao Lin; Ming-Tai Cheng; Kah-Meng Chong; Hui-Chih Wang; Chih-Wei Yang; Mao-Wei Liao; Chen-Hsiung Wang; Yu-Chun Chien; Chi-Hung Lin; Yueh-Ping Liu; Bin-Chou Lee; Kuo-Long Chien; Mei-Shu Lai; Matthew Huei-Ming Ma
Journal:  Resuscitation       Date:  2013-09-19       Impact factor: 5.262

2.  Outcomes from prehospital cardiac arrest in blunt trauma patients.

Authors:  Yoshihiro Moriwaki; Mitsugi Sugiyama; Toshiro Yamamoto; Yoshio Tahara; Hiroshi Toyoda; Takayuki Kosuge; Nobuyuki Harunari; Masayuki Iwashita; Shinju Arata; Noriyuki Suzuki
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

3.  Analysis of out-of-hospital cardiac arrest in Croatia - survival, bystander cardiopulmonary resuscitation, and impact of physician's experience on cardiac arrest management: a single center observational study.

Authors:  Anita Lukić; Ileana Lulić; Dinka Lulić; Zoran Ognjanović; Davorin Cerovečki; Siniša Telebar; Ivica Mašić
Journal:  Croat Med J       Date:  2016-12-31       Impact factor: 1.351

4.  Outcomes following cardiopulmonary resuscitation in an emergency department of a low- and middle-income country.

Authors:  Umme Salama Moosajee; Syed Ghazanfar Saleem; Sundus Iftikhar; Lubna Samad
Journal:  Int J Emerg Med       Date:  2018-10-01

5.  Clinical Predictive Models of Sudden Cardiac Arrest: A Survey of the Current Science and Analysis of Model Performances.

Authors:  Richard T Carrick; Jinny G Park; Hannah L McGinnes; Christine Lundquist; Kristen D Brown; W Adam Janes; Benjamin S Wessler; David M Kent
Journal:  J Am Heart Assoc       Date:  2020-08-13       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.